Neos Therapeutics, Inc.
Industry
- Pharmaceuticals
- Drug Delivery
- Controlled Release
- Drug Delivery
Latest on Neos Therapeutics, Inc.
Recent biopharmaceutical initial public offerings show that the IPO boom is not limited to the US, and illustrate the challenges of going public in any market. US stock values have plummeted in recent
Deborah Dunsire has been appointed president and CEO of H. Lundbeck AS , as of Sept. 1, 2018. Anders Götzsche , who has been acting as interim CEO and CFO since November 2017, will resume his po
The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer
IN VITRO DIAGNOSTICS Financings CareDx Inc. Molecular diagnostics firm CareDx Inc. netted $18.8mm through the follow-on public offering of 4.99mm common shares (including full exercise of the over